Scientific Letters
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: May 15, 2024
Accepted: May 30, 2024
Accepted: May 30, 2024
966
Views
781
Downloads
117
HTML
Authors
Not available.
Downloads
Download data is not yet available.
Citations
How to Cite
“Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia”. (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024057. doi:10.4084/MJHID.2024.057.
Copyright (c) 2024 Håkon Reikvam, Ingvild Jenssen Lægreid, Ingvild Hausberg Sørvoll, Tom Sollid, Trude Victoria Mørtberg, Maria Therese Ahlén, Silje Johansen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
